Mouse models of altered protein kinase A signaling

Endocrine-Related Cancer

Volumn 16, Issue 3, 2009, Pages 773-793

  Kirschner, Lawrence S ^a   Yin, Zhirong ^a   Jones, Georgette N ^a   Mahoney, Emilia ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; MERLIN; PROTEIN KINASE A REGULATORY SUBUNIT 1A; PROTEIN KINASE A REGULATORY SUBUNIT 1B; PROTEIN KINASE A REGULATORY SUBUNIT 2A; PROTEIN KINASE A REGULATORY SUBUNIT 2B; REGULATORY SUBUNIT TYPE 1 ALPHA OF PROTEIN KINASE A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

CATALYSIS; ENZYME ACTIVITY; GENOTYPE; HUMAN; HYPOPHYSIS TUMOR; KNOCKOUT MOUSE; MYXOMA; NEURAL CREST; NEURILEMOMA; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE TARGETING; GENE TRANSFER TECHNIQUES; HUMANS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION;

EID: 72749084368     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0068     Document Type: Review

References (176)

1. Abel T & Nguyen PV 2008 Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. Progress in Brain Research 169 97-115.
2. Abel T, Nguyen PV, Barad M, Deuel TA, Kandel ER & Bourtchouladze R 1997 Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88 615-626. (Pubitemid 27152404)
3. Alfthan K, Heiska L, Gronholm M, Renkema GH & Carpen O 2004 Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization. Journal of Biological Chemistry 279 18559-18566. (Pubitemid 38623276)
4. Amieux PS, Cummings DE, Motamed K, Brandon EP, Wailes LA, Le K, Idzerda RL & McKnight GS 1997 Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. Journal of Biological Chemistry 272 3993-3998. (Pubitemid 27078459)
5. Amieux PS, Howe DG, Knickerbocker H, Lee DC, Su T, Laszlo GS, Idzerda RL & McKnight GS 2002 Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. Journal of Biological Chemistry 277 27294-27304. (Pubitemid 34951748)
6. Angelo R & Rubin CS 1998 Molecular characterization of an anchor protein (AKAPCE) that binds the RI subunit (RCE) of type I protein kinase A from Caenorhabditis elegans. Journal of Biological Chemistry 273 14633-14643. (Pubitemid 28319189)
7. Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA, Marks AR & Olson EN 2001 Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circulation Research 89 997-1004. (Pubitemid 34640866)
8. Barlier A, Gunz G, Zamora AJ, Morange-Ramos I, Figarella-Branger D, Dufour H, Enjalbert A & Jaquet P 1998 Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. Journal of Clinical Endocrinology and Metabolism 83 1604-1610. (Pubitemid 28501029)
9. Barradeau S, Imaizumi-Scherrer T, Weiss MC & Faust DM 2000 Alternative 5′-exons of the mouse cAMP-dependent protein kinase subunit RIalpha gene are conserved and expressed in both a ubiquitous and tissue-restricted fashion. FEBS Letters 476 272-276. (Pubitemid 30410831)
10. Beene DL & Scott JD 2007 A-kinase anchoring proteins take shape. Current Opinion in Cell Biology 19 192-198.
11. Belyamani M, Gangolli EA & Idzerda RL 2001 Reproductive function in protein kinase inhibitor-deficient mice. Molecular and Cellular Biology 21 3959-3963.
12. Bertherat J 2006 Carney complex (CNC). Orphanet Journal of Rare Diseases 1 1-6.
13. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C et al. 2003 Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Research 63 5308-5319.
14. Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC et al. 2000 Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. Journal of Molecular and Cellular Cardiology 32 817-830.
15. Brandon EP, Zhuo M, Huang YY, Qi M, Gerhold KA, Burton KA, Kandel ER, McKnight GS & Idzerda RL 1995 Hippocampal long-term depression and depotentiation are defective in mice carrying a targeted disruption of the gene encoding the RI beta subunit of cAMP-dependent protein kinase. PNAS 92 8851-8855.
16. Brandon EP, Logue SF, Adams MR, Qi M, Sullivan SP, Matsumoto AM, Dorsa DM, Wehner JM, McKnight GS & Idzerda RL 1998 Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice. Journal of Neuroscience 18 3639-3649. (Pubitemid 28225672)
17. Bruneau BG 2002 Transcriptional regulation of vertebrate cardiac morphogenesis. Circulation Research 90 509-519. (Pubitemid 34640900)
18. Budovskaya YV, Stephan JS, Deminoff SJ & Herman PK 2005 An evolutionary proteomics approach identifies substrates of the cAMP-dependent protein kinase. PNAS 102 13933-13938. (Pubitemid 41377681)
19. 2+ channel activity by cAMP-dependent protein kinase. PNAS 94 11067-11072.
20. Burton KA, Treash-Osio B, Muller CH, Dunphy EL & Mcknight GS 1999 Deletion of type llalpha regulatory subunit delocalizes protein kinase A in mouse sperm without affecting motility or fertilization. Journal of Biological Chemistry 274 24131-24136. (Pubitemid 129528458)
21. Burton KA, McDermott DA, Wilkes D, Poulsen MN, Nolan MA, Goldstein M, Basson CT & McKnight GS 2006 Haploinsufficiency at the protein kinase A RI alpha gene locus leads to fertility defects in male mice and men. Molecular Endocrinology 20 2504-2513. (Pubitemid 44496418)
22. Carney JA 1990 Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. American Journal of Surgical Pathology 14 206-222.
23. Cetani F, Tonacchera M, Pinchera A, Barsacchi R, Basolo F, Miccoli P & Pacini F 1999 Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas. Journal of Endocrinological Investigation 22 273-278. (Pubitemid 29224326)
24. Cichowski K, Santiago S, Jardim M, Johnson BW & Jacks T 2003 Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes and Development 17 449-454. (Pubitemid 36258759)
25. Clegg CH, Correll LA, Cadd GG & McKnight GS 1987 Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit. Journal of Biological Chemistry 262 13111-13119.
26. Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB & Montminy M 2003 Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Molecular Cell 11 1101-1108. (Pubitemid 36566330)
27. Corbin JD, Sugden PH, Lincoln TM & Keely SL 1977 Compartmentalization of adenosine 3′:5′-monophosphate and adenosine 3′:5′- monophosphate-dependent protein kinase in heart tissue. Journal of Biological Chemistry 252 3854-3861. (Pubitemid 8127237)
28. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL & McKnight GS 1996 Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature 382 622-626. (Pubitemid 26268953)
29. Czyzyk TA, Sikorski MA, Yang L & McKnight GS 2008 Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice. PNAS 105 276-281.
30. Dasgupta B & Gutmann DH 2005 Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. Journal of Neuroscience 25 5584-5594. (Pubitemid 40800650)
31. Davis A, Hogarth K, Fernandes D, Solway J, Niu J, Kolenko V, Browning D, Miano JM, Orlov SN & Dulin NO 2003 Functional significance of protein kinase A activation by endothelin-1 and ATP: negative regulation of SRFdependent gene expression by PKA. Cellular Signalling 15 597-604. (Pubitemid 36385165)
32. Dell'Acqua ML, Smith KE, Gorski JA, Horne EA, Gibson ES & Gomez LL 2006 Regulation of neuronal PKA signaling through AKAP targeting dynamics. European Journal of Cell Biology 85 627-633.
33. Desseyn JL, Burton KA & McKnight GS 2000 Expression of a nonmyristylated variant of the catalytic subunit of protein kinase A during male germ-cell development. PNAS 97 6433-6438.
34. Diviani D, Baisamy L & Appert-Collin A 2006 AKAP-Lbc: a molecular scaffold for the integration of cyclic AMP and Rho transduction pathways. European Journal of Cell Biology 85 603-610. (Pubitemid 43884230)
35. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS & Scott JD 2005 The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437 574-578. (Pubitemid 41613557)
36. Dodge-Kafka KL, Bauman A & Kapiloff MS 2008 A-kinase anchoring proteins as the basis for cAMP signaling. Handbook of Experimental Pharmacology 186 3-14.
37. Durocher D, Charron F, Warren R, Schwartz RJ & Nemer M 1997 The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO Journal 16 5687-5696. (Pubitemid 27399860)
38. Ellerbroek SM, Wennerberg K & Burridge K 2003 Serine phosphorylation negatively regulates RhoA in vivo. Journal of Biological Chemistry 278 19023-19031. (Pubitemid 36799287)
39. Engelhardt S, Hein L, Wiesmann F & Lohse MJ 1999 Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. PNAS 96 7059-7064. (Pubitemid 29275009)
40. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML & McCutcheon IE 2004 The prevalence of pituitary adenomas: a systematic review. Cancer 101 613-619. (Pubitemid 38970613)
41. Feliciello A, Gottesman ME & Avvedimento EV 2001 The biological functions of A-kinase anchor proteins. Journal of Molecular Biology 308 99-114. (Pubitemid 33043558)
42. Fentzke RC, Korcarz CE, Lang RM, Lin H & Leiden JM 1998 Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. Journal of Clinical Investigation 101 2415-2426. (Pubitemid 28270436)
43. Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA & Paschke R 1997a Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. Journal of Clinical Endocrinology and Metabolism 82 3885-3891. (Pubitemid 27509388)
44. Fuhrer D, Wonerow P, Willgerodt H & Paschke R 1997b Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 82 4234-4238. (Pubitemid 27525546)
45. Gangolli EA, Belyamani M, Muchinsky S, Narula A, Burton KA, McKnight GS, Uhler MD & Idzerda RL 2000 Deficient gene expression in protein kinase inhibitor alpha Null mutant mice. Molecular and Cellular Biology 20 3442-3448. (Pubitemid 30243890)
46. Gao X, Jin C, Ren J, Yao X & Xue Y 2008 Proteome-wide prediction of PKA phosphorylation sites in eukaryotic kingdom. Genomics 92 457-463.
47. Goldman BI, Frydman C, Harpaz N, Ryan SF & Loiterman D 1987 Glandular cardiac myxomas. Histologic, immunohistochemical, and ultrastructural evidence of epithelial differentiation. Cancer 59 1767-1775.
48. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos S, Robinson-White A, Lenherr S, Weinberg FD, Claflin E, Meoli E, Cho-Chung YS et al. 2004a Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Research 64 8811-8815. (Pubitemid 39665482)
49. Griffin KJ, Kirschner LS, Matyakhina L, Stergiopoulos SG, Robinson-White A, Lenherr SM, Weinberg FD, Claflin ES, Batista D, Bourdeau I et al. 2004b A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. Journal of Medical Genetics 41 923-931.
50. Gronholm M, Vossebein L, Carlson CR, Kuja-Panula J, Teesalu T, Alfthan K, Vaheri A, Rauvala H, Herberg FW, Tasken K et al. 2003 Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A. Journal of Biological Chemistry 278 41167-41172. (Pubitemid 37280942)
51. Guilding C, McNair K, Stone TW & Morris BJ 2007 Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. European Journal of Neuroscience 25 99-105. (Pubitemid 46096226)
52. Guthrie CR, Skalhegg BS & McKnight GS 1997 Two novel brain-specific splice variants of the murine Cbeta gene of cAMP-dependent protein kinase. Journal of Biological Chemistry 272 29560-29565. (Pubitemid 27508043)
53. Hall DD, Davare MA, Shi M, Allen ML, Weisenhaus M, McKnight GS & Hell JW 2007 Critical role of cAMP-dependent protein kinase anchoring to the L-type calcium channel Cav1.2 via A-kinase anchor protein 150 in neurons. Biochemistry 46 1635-1646. (Pubitemid 46256761)
54. Harada A, Teng J, Takei Y, Oguchi K & Hirokawa N 2002 MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. Journal of Cell Biology 158 541-549. (Pubitemid 34851712)
55. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC & Chen H 2008a Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clinical Endocrinology [in press].
56. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC & Chen H 2008b Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. Journal of Clinical Endocrinology and Metabolism 93 809-814.
57. Hemmings BA 1986 cAMP mediated proteolysis of the catalytic subunit of cAMP-dependent protein kinase. FEBS Letters 196 126-130. (Pubitemid 16048196)
58. Higuchi H, Yamashita T, Yoshikawa H & Tohyama M 2003 PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts. EMBO Journal 22 1790-1800. (Pubitemid 36460136)
59. Hino S, Tanji C, Nakayama KI & Kikuchi A 2005 Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination. Molecular and Cellular Biology 25 9063-9072. (Pubitemid 41429094)
60. Hoang T, Fenne IS, Cook C, Borud B, Bakke M, Lien EA & Mellgren G 2004 cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. Journal of Biological Chemistry 279 49120-49130. (Pubitemid 39625795)
61. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP et al. 2006 A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nature Genetics 38 794-800.
62. Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libe R, Patronas Y, Robinson-White A, Remmers E et al. 2008 A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. European Journal of Human Genetics 16 1245-1253.
63. Howe AK 2004 Regulation of actin-based cell migration by cAMP/PKA. Biochimica et Biophysica Acta 1692 159-174. (Pubitemid 38891772)
64. Howe DG, Wiley JC & McKnight GS 2002 Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. Molecular and Cellular Neurosciences 20 515-524.
65. Howe DG, Clarke CM, Yan H, Willis BS, Schneider DA, McKnight GS & Kapur RP 2006 Inhibition of protein kinase A in murine enteric neurons causes lethal intestinal pseudo-obstruction. Journal of Neurobiology 66 256-272. (Pubitemid 43202763)
66. Huang YY & Kandel ER 1996 Modulation of both the early and the late phase of mossy fiber LTP by the activation of beta-adrenergic receptors. Neuron 16 611-617.
67. Huang YY, Kandel ER, Varshavsky L, Brandon EP, Qi M, Idzerda RL, McKnight GS & Bourtchouladze R 1995 A genetic test of the effects of mutations in PKA on mossy fiber LTP and its relation to spatial and contextual learning. Cell 83 1211-1222. (Pubitemid 26007811)
68. Huang W, Zhou X, Lefebvre V & de Crombrugghe B 2000 Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Molecular and Cellular Biology 20 4149-4158. (Pubitemid 30314512)
69. Huang Y, Roelink H & McKnight GS 2002 Protein kinase A deficiency causes axially localized neural tube defects in mice. Journal of Biological Chemistry 277 19889-19896. (Pubitemid 34967509)
70. Huang SY, Tsai ML, Chen GY, Wu CJ & Chen SH 2007 A systematic MS-based approach for identifying in vitro substrates of PKA and PKG in rat uteri. Journal of Proteome Research 6 2674-2684.
71. Izawa I, Tamaki N & Saya H 1996 Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Letters 382 53-59. (Pubitemid 26092233)
72. Jarnaess E & Tasken K 2007 Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochemical Society Transactions 35 931-937. (Pubitemid 350206399)
73. Jemec B 1977 Studies of the tumorigenic effect of two goitrogens. Cancer 40 2188-2202. (Pubitemid 8239708)
74. Johannessen CM, Reczek EE, James MF, Brems H, Legius E & Cichowski K 2005 The NF1 tumor suppressor critically regulates TSC2 and mTOR. PNAS 102 8573-8578. (Pubitemid 40862777)
75. Johannessen CM, Johnson BW, Williams SM, Chan AW, Reczek EE, Lynch RC, Rioth MJ, McClatchey A, Ryeom S & Cichowski K 2008 TORC1 is essential for NF1-associated malignancies. Current Biology 18 56-62.
76. Johansson L 1989 Histogenesis of cardiac myxomas. An immunohistochemical study of 19 cases, including one with glandular structures, and review of the literature. Archives of Pathology and Laboratory Medicine 113 735-741.
77. Jones GN, Tep C, Towns WH, Mihai G, Tonks ID, Kay GF, Schmalbrock P, Stemmer-Rachamimov AO, Yoon SO & Kirschner LS 2008 Tissue-specific ablation of Prkar1a causes Schwannomas by suppressing NF protein production. Neoplasia 10 1213-1221.
78. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM, Czirjak S, Kirschner LS, Stratakis CA, Korbonits M et al. 2002 Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clinical Endocrinology 57 443-448. (Pubitemid 35216295)
79. Kim HA, Ratner N, Roberts TM & Stiles CD 2001 Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. Journal of Neuroscience 21 1110-1116. (Pubitemid 32128756)
80. Kinsella MG & Fitzharris TP 1980 Origin of cushion tissue in the developing chick heart: cinematographic recordings of in situ formation. Science 207 1359-1360.
81. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS & Stratakis CA 2000a Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nature Genetics 26 89-92. (Pubitemid 30692864)
82. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA & Stratakis CA 2000b Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Human Molecular Genetics 9 3037-3046. (Pubitemid 32000777)
83. Kirschner LS, Kusewitt DF, Matyakhina L, Towns WH II, Carney JA, Westphal H & Stratakis CA 2005 A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Research 65 4506-4514. (Pubitemid 40740784)
84. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA & Lefkowitz RJ 1995 Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268 1350-1353.
85. Lania AG, Mantovani G, Ferrero S, Pellegrini C, Bondioni S, Peverelli E, Braidotti P, Locatelli M, Zavanone ML, Ferrante E et al. 2004 Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Research 64 9193-9198.
86. Laulajainen M, Muranen T, Carpen O & Gronholm M 2008 Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton. Oncogene 27 3233-3243. (Pubitemid 351733388)
87. Ledent C, Dumont JE, Vassart G & Parmentier M 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO Journal 11 537-542.
88. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, Yatani A & Dorn GW II 2000 Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101 1707-1714. (Pubitemid 30196632)
89. Lohse MJ & Engelhardt S 2001 Protein kinase a transgenes: the many faces of cAMP. Circulation Research 89 938-940. (Pubitemid 34640859)
90. Lu Y, Allen M, Halt AR, Weisenhaus M, Dallapiazza RF, Hall DD, Usachev YM, McKnight GS & Hell JW 2007 Age-dependent requirement of AKAP150-anchored PKA and GluR2-lacking AMPA receptors in LTP. EMBO Journal 26 4879-4890. (Pubitemid 350191298)
91. Manning G, Whyte DB, Martinez R, Hunter T & Sudarsanam S 2002 The protein kinase complement of the human genome. Science 298 1912-1934. (Pubitemid 35425239)
92. Martin-Reay DG, Shattuck MC & Guthrie FW Jr 1991 Psammomatous melanotic schwannoma: an additional component of Carney's complex. Report of a case. American Journal of Clinical Pathology 95 484-489.
93. Marx SO & Marks AR 2002 Regulation of the ryanodine receptor in heart failure. Basic Research in Cardiology 97 I49-I51.
94. Mason HS, Latten MJ, Godoy LD, Horowitz B & Kenyon JL 2002 Modulation of Kv1.5 currents by protein kinase A, tyrosine kinase, and protein tyrosine phosphatase requires an intact cytoskeleton. Molecular Pharmacology 61 285-293. (Pubitemid 34112802)
95. Mauban JR, O'Donnell M, Warrier S, Manni S & Bond M 2009 AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology 24 78-87.
96. Mayr B & Montminy M 2001 Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Reviews. Molecular Cell Biology 2 599-609. (Pubitemid 33674011)
97. McConnachie G, Langeberg LK & Scott JD 2006 AKAP signaling complexes: getting to the heart of the matter. Trends in Molecular Medicine 12 317-323. (Pubitemid 44110003)
98. McConnell BK, Popovic Z, Mal N, Lee K, Bautista J, Forudi F, Schwartzman R, Jin JP, Penn M & Bond M 2009 Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. Journal of Biological Chemistry 284 1583-1592.
99. Mendez M & LaPointe MC 2005 PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation. American Journal of Physiology. Heart and Circulatory Physiology 288 H2111-H2117. (Pubitemid 40604094)
100. Michel JJ & Scott JD 2002 AKAP mediated signal transduction. Annual Review of Pharmacology and Toxicology 42 235-257.
101. Michel JJ, Townley IK, Dodge-Kafka KL, Zhang F, Kapiloff MS & Scott JD 2005 Spatial restriction of PDK1 activation cascades by anchoring to mAKAPalpha. Molecular Cell 20 661-672. (Pubitemid 41740689)
102. Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R & Feunteun J 1994 Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice. PNAS 91 10488-10492. (Pubitemid 24329023)
103. Miki K, Willis WD, Brown PR, Goulding EH, Fulcher KD & Eddy EM 2002 Targeted disruption of the Akap4 gene causes defects in sperm flagellum and motility. Developmental Biology 248 331-342. (Pubitemid 35002093)
104. Montminy M 1997 Transcriptional regulation by cyclic AMP. Annual Review of Biochemistry 66 807-822.
105. Nadella KS & Kirschner LS 2005 Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins. Cancer Research 65 10307-10315.
106. 2+ sparklets and angiotensin II-induced hypertension. Circulation Research 102 e1-e11.
107. Neuberger G, Schneider G & Eisenhaber F 2007 pkaPS: prediction of protein kinase A phosphorylation sites with the simplified kinase-substrate binding model. Biology Direct 2 1. (Pubitemid 46711866)
108. Newhall KJ, Cummings DE, Nolan MA & McKnight GS 2005 Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse. Molecular Endocrinology 19 982-991.
109. Newhall KJ, Criniti AR, Cheah CS, Smith KC, Kafer KE, Burkart AD & McKnight GS 2006 Dynamic anchoring of PKA is essential during oocyte maturation. Current Biology 16 321-327.
110. Nguyen GH, French R & Radhakrishna H 2004 Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton. Cellular Signalling 16 1141-1151. (Pubitemid 38900517)
111. Nolan MA, Sikorski MA & McKnight GS 2004 The role of uncoupling protein 1 in the metabolism and adiposity of RII beta-protein kinase A-deficient mice. Molecular Endocrinology 18 2302-2311.
112. Noveen A, Jiang TX & Chuong CM 1996 cAMP, an activator of protein kinase A, suppresses the expression of sonic hedgehog. Biochemical and Biophysical Research Communications 219 180-185. (Pubitemid 26071624)
113. Oksvold MP, Funderud A, Kvissel AK, Skarpen E, Henanger H, Huitfeldt HS, Skalhegg BS & Orstavik S 2008 Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit. BMC Cell Biology 9 16. (Pubitemid 351584172)
114. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J, Araujo Vilar D, Argueso R, Barca O, Botana M et al. 2008 Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. European Journal of Endocrinology 159 623-631.
115. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J & Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365 649-651. (Pubitemid 23350535)
116. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE & Vassart G 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 82 2695-2701. (Pubitemid 27337896)
117. Pavel E, Nadella K, Towns WH II & Kirschner LS 2008 Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A. Molecular Endocrinology 22 430-440. (Pubitemid 351185940)
118. Pelton PD, Sherman LS, Rizvi TA, Marchionni MA, Wood P, Friedman RA & Ratner N 1998 Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene 17 2195-2209. (Pubitemid 28515373)
119. Person AD, Klewer SE & Runyan RB 2005 Cell biology of cardiac cushion development. International Review of Cytology 243 287-335. (Pubitemid 41557302)
120. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M et al. 2002 Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. PNAS 99 15462-15467. (Pubitemid 35407483)
121. Qi M, Zhuo M, Skalhegg BS, Brandon EP, Kandel ER, McKnight GS & Idzerda RL 1996 Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase. PNAS 93 1571-1576. (Pubitemid 26075166)
122. Qiao J, Huang F & Lum H 2003 PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. American Journal of Physiology. Lung Cellular and Molecular Physiology 284 L972-L980. (Pubitemid 36687132)
123. Rannels SR, Cobb CE, Landiss LR & Corbin JD 1985 The regulatory subunit monomer of cAMP-dependent protein kinase retains the salient kinetic properties of the native dimeric subunit. Journal of Biological Chemistry 260 3423-3430.
124. Rao Y, Fischer QS, Yang Y, McKnight GS, LaRue A & Daw NW 2004 Reduced ocular dominance plasticity and long-term potentiation in the developing visual cortex of protein kinase A RII alpha mutant mice. European Journal of Neuroscience 20 837-842. (Pubitemid 39036944)
125. Rebolledo B, Lai NC, Gao MH, Takahashi T, Roth DM, Baird SM & Hammond HK 2006 Adenylylcyclase gene transfer increases function of the failing heart. Human Gene Therapy 17 1043-1048. (Pubitemid 46076746)
126. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D, Wang J, Vassort G, Lederer WJ & Marks AR 2003 Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. Journal of Biological Chemistry 278 444-453. (Pubitemid 36043595)
127. Reynen K 1995 Cardiac Myxomas. New England Journal of Medicine 333 1610-1617.
128. Robinson-Steiner AM, Beebe SJ, Rannels SR & Corbin JD 1984 Microheterogeneity of type II cAMP-dependent protein kinase in various mammalian species and tissues. Journal of Biological Chemistry 259 10596-10605.
129. Rolli-Derkinderen M, Sauzeau V, Boyer L, Lemichez E, Baron C, Henrion D, Loirand G & Pacaud P 2005 Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circulation Research 96 1152-1160. (Pubitemid 40827690)
130. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X & Bertherat J 2002 Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Annals of the New York Academy of Sciences 968 65-74. (Pubitemid 34721872)
131. Roth DM, Gao MH, Lai NC, Drumm J, Dalton N, Zhou JY, Zhu J, Entrikin D & Hammond HK 1999 Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation 99 3099-3102. (Pubitemid 29289073)
132. Roth DM, Drumm JD, Bhargava V, Swaney JS, Gao MH & Hammond HK 2003 Cardiac-directed expression of adenylyl cyclase and heart rate regulation. Basic Research in Cardiology 98 380-387. (Pubitemid 37336625)
133. Ruehr ML, Russell MA & Bond M 2004 A-kinase anchoring protein targeting of protein kinase A in the heart. Journal of Molecular and Cellular Cardiology 37 653-665. (Pubitemid 39194557)
134. Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S & Suarez HG 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 11 1907-1911.
135. San Agustin JT & Witman GB 2001 Differential expression of the C(s) and Calpha1 isoforms of the catalytic subunit of cyclic 3′,5′- adenosine monophosphate-dependent protein kinase testicular cells. Biology of Reproduction 65 151-164.
136. Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K, Prezant TR, Marx SJ, Farrell WE, Clayton RN et al. 2002a PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. Journal of Medical Genetics 39 e78.
137. Sandrini F, Matyakhina L, Sarlis NJ, Kirschner LS, Farmakidis C, Gimm O & Stratakis CA 2002b Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. Genes, Chromosomes and Cancer 35 182-192. (Pubitemid 34919976)
138. Sauer B & Henderson N 1988 DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. PNAS 85 5166-5170.
139. Schnizler K, Shutov LP, Van Kanegan MJ, Merrill MA, Nichols B, McKnight GS, Strack S, Hell JW & Usachev YM 2008 Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. Journal of Neuroscience 28 4904-4917.
140. Schreyer SA, Cummings DE, McKnight GS & LeBoeuf RC 2001 Mutation of the RIIbeta subunit of protein kinase A prevents diet-induced insulin resistance and dyslipidemia in mice. Diabetes 50 2555-2562. (Pubitemid 33642774)
141. Shenker A, Weinstein LS, Sweet DE & Spiegel AM 1994 An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism 79 750-755. (Pubitemid 24286397)
142. Skalhegg BS & Tasken K 2000 Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Frontiers in Bioscience 5 D678-D693.
143. Skalhegg BS, Huang Y, Su T, Idzerda RL, McKnight GS & Burton KA 2002 Mutation of the Calpha subunit of PKA leads to growth retardation and sperm dysfunction. Molecular Endocrinology 16 630-639. (Pubitemid 34214581)
144. Solberg R, Sandberg M, Natarajan V, Torjesen PA, Hansson V, Jahnsen T & Tasken K 1997 The human gene for the regulatory subunit RI alpha of cyclic adenosine 3′, 5′-monophosphate-dependent protein kinase: two distinct promoters provide differential regulation of alternately spliced messenger ribonucleic acids. Endocrinology 138 169-181. (Pubitemid 27009421)
145. Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G et al. 2004 Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Research 64 3718-3724.
146. Stergiopoulos SG, Abu-Asab MS, Tsokos M & Stratakis CA 2004 Pituitary pathology in Carney complex patients. Pituitary 7 73-82. (Pubitemid 40372985)
147. Stratakis CA, Kirschner LS & Carney JA 2001 Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. Journal of Clinical Endocrinology and Metabolism 86 4041-4046.
148. Sun F, Hug MJ, Bradbury NA & Frizzell RA 2000 Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrin. Journal of Biological Chemistry 275 14360-14366. (Pubitemid 30339719)
149. Sutherland EW & Rall TW 1958 Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. Journal of Biological Chemistry 232 1077-1091.
150. Takahashi T, Tang T, Lai NC, Roth DM, Rebolledo B, Saito M, Lew WY, Clopton P & Hammond HK 2006 Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation 114 388-396. (Pubitemid 44264820)
151. Tamaki H 2007 Glucose-stimulated cAMP-protein kinase A pathway in yeast Saccharomyces cerevisiae. Journal of Bioscience and Bioengineering 104 245-250. (Pubitemid 350102395)
152. The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF, Hariharan IK & Bernards A 1997 Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 276 791-794.
153. Thevelein JM, Bonini BM, Castermans D, Haesendonckx S, Kriel J, Louwet W, Thayumanavan P, Popova Y, Rubio-Texeira M, Schepers W et al. 2008 Novel mechanisms in nutrient activation of the yeast protein kinase A pathway. Acta Microbiologica et Immunologica Hungarica 55 75-89.
154. Tingley WG, Pawlikowska L, Zaroff JG, Kim T, Nguyen T, Young SG, Vranizan K, Kwok PY, Whooley MA & Conklin BR 2007 Gene-trapped mouse embryonic stem cell-derived cardiac myocytes and human genetics implicate AKAP10 in heart rhythm regulation. PNAS 104 8461-8466. (Pubitemid 47175510)
155. Tokuo H, Yunoue S, Feng L, Kimoto M, Tsuji H, Ono T, Saya H & Araki N 2001 Phosphorylation of neurofibromin by cAMP-dependent protein kinase is regulated via a cellular association of N(G),N(G)-dimethylarginine dimethylaminohydrolase. FEBS Letters 494 48-53. (Pubitemid 32289370)
156. Tonks ID, Nurcombe V, Paterson C, Zournazi A, Prather C, Mould AW & Kay GF 2003 Tyrosinase-Cre mice for tissue-specific gene ablation in neural crest and neuroepithelial- derived tissues. Genesis 37 131-138. (Pubitemid 37486874)
157. Tunquist BJ, Hoshi N, Guire ES, Zhang F, Mullendorff K, Langeberg LK, Raber J & Scott JD 2008 Loss of AKAP150 perturbs distinct neuronal processes in mice. PNAS 105 12557-12562.
158. Uhler MD, Carmichael DF, Lee DC, Chrivia JC, Krebs EG & McKnight GS 1986a Isolation of cDNA clones coding for the catalytic subunit of mouse cAMP-dependent protein kinase. PNAS 83 1300-1304. (Pubitemid 16016116)
159. Uhler MD, Chrivia JC & McKnight GS 1986b Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. Journal of Biological Chemistry 261 15360-15363. (Pubitemid 17208750)
160. Vallar L, Spada A & Giannattasio G 1987 Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330 566-568.
161. Vanfleteren JR & De Vreese A 1997 Modulation of kinase activities in dauers and in long-lived mutants of Caenorhabditis elegans. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 52 B212-B216.
162. Vatner DE, Asai K, Iwase M, Ishikawa Y, Wagner TE, Shannon RP, Homcy CJ & Vatner SF 1998 Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. Journal of Clinical Investigation 101 1916-1922.
163. Veugelers M, Wilkes D, Burton K, McDermott DA, Song Y, Goldstein MM, La Perle K, Vaughan CJ, O'Hagan A, Bennett KR et al. 2004 Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. PNAS 101 14222-14227.
164. Vijayaraghavan S, Goueli SA, Davey MP & Carr DW 1997 Protein kinase A-anchoring inhibitor peptides arrest mammalian sperm motility. Journal of Biological Chemistry 272 4747-4752. (Pubitemid 27090017)
165. Walsh DA, Perkins JP & Krebs EG 1968 An adenosine 3′,5′-monophosphate-dependant protein kinase from rabbit skeletal muscle. Journal of Biological Chemistry 243 3763-3765.
166. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E & Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New England Journal of Medicine 325 1688-1695.
167. Weinstein LS, Yu S, Warner DR & Liu J 2001 Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocrine Reviews 22 675-705. (Pubitemid 32955250)
168. Woodford TA, Correll LA, McKnight GS & Corbin JD 1989 Expression and characterization of mutant forms of the type I regulatory subunit of cAMP-dependent protein kinase. The effect of defective cAMP binding on holoenzyme activation. Journal of Biological Chemistry 264 13321-13328.
169. Yamasaki H, Mizusawa N, Nagahiro S, Yamada S, Sano T, Itakura M & Yoshimoto K 2003 GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. Clinical Endocrinology 58 464-470. (Pubitemid 36390619)
170. Yang Y, Mahaffey CL, Berube N & Frankel WN 2006 Interaction between fidgetin and protein kinase A-anchoring protein AKAP95 is critical for palatogenesis in the mouse. Journal of Biological Chemistry 281 22352-22359. (Pubitemid 44181937)
171. Yin Z, Jones GN, Towns WH II, Zhang X, Abel ED, Binkley PF, Jarjoura D & Kirschner LS 2008a Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. Circulation 117 1414-1422.
172. Yin Z, Williams-Simons L, Parlow AF, Asa S & Kirschner LS 2008b Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Molecular Endocrinology 22 380-387. (Pubitemid 351185937)
173. Yin Z, Williams-Simons L, Rawahneh L, Asa S & Kirschner LS 2008c Development of a pituitary-specific cre line targeted to the Pit-1 lineage. Genesis 46 37-42.
174. Yonemoto W, McGlone ML & Taylor SS 1993 N-myristylation of the catalytic subunit of cAMP-dependent protein kinase conveys structural stability. Journal of Biological Chemistry 268 2348-2352. (Pubitemid 23057850)
175. Zeiger MA, Saji M, Gusev Y, Westra WH, Takiyama Y, Dooley WC, Kohn LD & Levine MA 1997 Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology 138 3133-3140. (Pubitemid 27345661)
176. Zhu W & Saba S 2003 Cardiac electrophysiologic abnormalities in the CREBA133 transgenic mouse model of idiopathic dilated cardiomyopathy. Journal of Cardiovascular Electrophysiology 14 982-989. (Pubitemid 37115163)